Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays from Prostate Cancer Update

Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

29 minutes Posted May 26, 2026 at 1:00 pm.

Circulating tumor DNA (ctDNA)-guided adjuvant therapy with atezolizumab for muscle-invasive bladder cancer (MIBC)

Use of ctDNA in guiding systemic treatment selection for patients with urothelial bladder cancer

ctDNA analyses with perioperative durvalumab for MIBC in the Phase III NIAGARA study

New research advances in the monitoring and management of urothelial bladder cancer

0:00

29:57

Download MP3

Share at current time

Show notes

Professor Thomas Powles from Barts Cancer Institute in London, United Kingdom, discusses recent developments with circulating tumor DNA assays in the management of urothelial bladder cancer.

CME information and select publications here.

← See all 66 episodes of Prostate Cancer Update